WallStreetZenWallStreetZen

NYSE: HCA
Hca Healthcare Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HCA

Based on 17 analysts offering 12 month price targets for Hca Healthcare Inc

Min Forecast
$370.00-23.29%
Avg Forecast
$468.53-2.87%
Max Forecast
$525.00+8.84%

Should I buy or sell HCA stock?

Based on 17 analysts offering ratings for Hca Healthcare Inc.

Buy
Strong Buy
8 analysts 47.06%
Buy
3 analysts 17.65%
Hold
6 analysts 35.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Strong Buy" agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their HCA stock forecasts and price targets.

HCA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-13Find Out Why
lockedlocked$00.00+00.00%2025-10-28Find Out Why
lockedlocked$00.00+00.00%2025-10-27
lockedlocked$00.00+00.00%2025-10-27
lockedlocked$00.00+00.00%2025-10-27
TD Cowen
Bottom 9%
9
Strong BuyMaintains$490.00+1.59%2025-10-27
RBC Capital
Top 18%
83
BuyMaintains$482.00-0.07%2025-10-27
Stephens & Co.
Top 33%
68
Strong BuyMaintains$500.00+3.66%2025-10-27
Truist Securities
Top 11%
90
Strong BuyMaintains$495.00+2.62%2025-10-27Find out why
Oppenheimer
Bottom 11%
11
BuyMaintains$500.00+3.66%2025-10-27

1 of 2

Forecast return on equity

Is HCA forecast to generate an efficient return?

Company
-157.75%
Industry
-91.44%
Market
226.6%
HCA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HCA forecast to generate an efficient return on assets?

Company
14.09%
Industry
11.09%
HCA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HCA earnings per share forecast

What is HCA's earnings per share in the next 3 years based on estimates from 27 analysts?

Avg 1 year Forecast
$27.85+6.36%
Avg 2 year Forecast
$29.96+14.42%
Avg 3 year Forecast
$33.26+27.03%
HCA's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

HCA revenue forecast

What is HCA's revenue in the next 3 years based on estimates from 26 analysts?

Avg 1 year Forecast
$76.5B+2.88%
Avg 2 year Forecast
$79.9B+7.46%
Avg 3 year Forecast
$84.0B+12.99%
HCA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HCA earnings growth forecast

How is HCA forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
8.04%
Industry
11.75%
Market
42.48%
HCA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HCA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HCA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HCA revenue growth forecast

How is HCA forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
4.1%
Industry
4.01%
Market
25.74%
HCA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HCA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HCA vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
HCA$482.35$468.53-2.87%Buy
THC$197.71$229.80+16.23%Strong Buy
UHS$224.58$238.10+6.02%Buy
FMS$23.38N/AN/A
EHC$106.85$148.00+38.51%Strong Buy
View Top Medical Care Facility Stocks

Hca Healthcare Stock Forecast FAQ

Is Hca Healthcare Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 17 Wall Street analysts covering (NYSE: HCA) stock is to Buy HCA stock.

Out of 17 analysts, 8 (47.06%) are recommending HCA as a Strong Buy, 3 (17.65%) are recommending HCA as a Buy, 6 (35.29%) are recommending HCA as a Hold, 0 (0%) are recommending HCA as a Sell, and 0 (0%) are recommending HCA as a Strong Sell.

If you're new to stock investing, here's how to buy Hca Healthcare stock.

What is HCA's earnings growth forecast for 2025-2027?

(NYSE: HCA) Hca Healthcare's forecast annual earnings growth rate of 8.04% is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 11.75%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.48%.

Hca Healthcare's earnings in 2025 is $6,344,000,000.On average, 27 Wall Street analysts forecast HCA's earnings for 2025 to be $6,354,127,604, with the lowest HCA earnings forecast at $5,915,014,082, and the highest HCA earnings forecast at $6,761,613,451. On average, 27 Wall Street analysts forecast HCA's earnings for 2026 to be $6,835,571,094, with the lowest HCA earnings forecast at $6,093,918,100, and the highest HCA earnings forecast at $7,528,344,955.

In 2027, HCA is forecast to generate $7,588,725,061 in earnings, with the lowest earnings forecast at $6,782,698,567 and the highest earnings forecast at $8,278,304,207.

What is HCA's revenue growth forecast for 2025-2027?

(NYSE: HCA) Hca Healthcare's forecast annual revenue growth rate of 4.1% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.74%.

Hca Healthcare's revenue in 2025 is $74,372,000,000.On average, 26 Wall Street analysts forecast HCA's revenue for 2025 to be $17,459,343,482,900, with the lowest HCA revenue forecast at $16,849,152,994,300, and the highest HCA revenue forecast at $18,242,733,141,600. On average, 26 Wall Street analysts forecast HCA's revenue for 2026 to be $18,237,941,069,700, with the lowest HCA revenue forecast at $17,219,511,694,000, and the highest HCA revenue forecast at $19,312,506,144,800.

In 2027, HCA is forecast to generate $19,176,274,386,500 in revenue, with the lowest revenue forecast at $18,248,209,795,200 and the highest revenue forecast at $20,352,613,941,000.

What is HCA's forecast return on assets (ROA) for 2025-2028?

(NYSE: HCA) forecast ROA is 14.09%, which is higher than the forecast US Medical Care Facilities industry average of 11.09%.

What is HCA's Price Target?

According to 17 Wall Street analysts that have issued a 1 year HCA price target, the average HCA price target is $468.53, with the highest HCA stock price forecast at $525.00 and the lowest HCA stock price forecast at $370.00.

On average, Wall Street analysts predict that Hca Healthcare's share price could fall to $468.53 by Nov 13, 2026. The average Hca Healthcare stock price prediction forecasts a potential downside of 2.87% from the current HCA share price of $482.35.

What is HCA's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: HCA) Hca Healthcare's current Earnings Per Share (EPS) is $26.18. On average, analysts forecast that HCA's EPS will be $27.85 for 2025, with the lowest EPS forecast at $25.92, and the highest EPS forecast at $29.63. On average, analysts forecast that HCA's EPS will be $29.96 for 2026, with the lowest EPS forecast at $26.71, and the highest EPS forecast at $32.99. In 2027, HCA's EPS is forecast to hit $33.26 (min: $29.72, max: $36.28).

What is HCA's forecast return on equity (ROE) for 2025-2028?

(NYSE: HCA) forecast ROE is -157.75%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.